Sanofi to acquire Blueprint Medicines for $9.1 Billion
On Jun. 2, 2025, Sanofi and Blueprint Medicines, a US-based, publicly traded biopharmaceutical company specializing in systemic mastocytosis…
On Jun. 2, 2025, Sanofi and Blueprint Medicines, a US-based, publicly traded biopharmaceutical company specializing in systemic mastocytosis…
On May 30, 2025, researchers from Curtin Medical School reported that they have found that men who carry…
On May 30, 2025, Pfizer announced statistically significant and clinically meaningful survival results from the Phase 3 BREAKWATER…
On May 29, 2025, Broad Institute researchers announced they have developed a technology that provides new insight into…
On May 29, 2025, The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
On May 27, 2025, a research team from the University of Washington Medical Center and the University of…
On May 23, 2025 a Boston University School of Public Health (BUSPH) led study revealed that there were…
On May 22, 2025, Gladstone scientists unveiled a powerful computation tool that integrates different forms of biological data…
On May 20, 2025, the World Health Organization (WHO) announced that world leaders pledged at least an additional…
On May 19, 2025, researchers at the Broad Institute Ben Neale and Mark Daly are co-leading the study,…
On May 19, 2025, Regeneron Pharmaceuticals announced it has been named the successful bidder in the bankruptcy auction…
On May 19, 2025, researchers from the Karlsruhe Institute of Technology (KIT) announced they have have discovered how…
On May 18, 2025, a surgical team from the University of California, Los Angeles Health (UCLA Health) announced…
On May 16, 2025, the U.S. Food and Drug Administration has cleared Fujirebio Diagnostics’ blood test to diagnose…
On May 15, 2025, Florida Republican Gov. Ron DeSantis signed a measure prohibiting local governments from adding fluoride…
On May 15, 2025, Amneal Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved Brekiya®…
On May 15, 2025, researchers at the Translational Genomics Research Institute (TGen), part of City of Hope, announced…
On May 14, 2025, The U.S. Food and Drug Administration (FDA) has approved AbbVie’s drug to treat adults…
On May 12, 2025, Roche announced it plans to invest up to $550 million in its Diagnostics site…
On May 12, 2025, Genentech announced plans to invest more than $700 million in a new 700,000 square…
On May 9, 2025, Teal Health® announced the Food and Drug Administration’s (FDA) approval of the Teal Wand™,…
On May 7, 2025, researchers at the University College London (UCL) and King’s College London announced that an…
On May 6, 2025, UT Southwestern Medical Center and Children’s Health℠ announced a historic nine-figure grant from the Moody Foundation…
On May 2, 2025, researchers at the Wellcome Sanger Institute, UCL, and the University of Cambridge announced they…
On Apr. 30, 2025, the U.S. Food and Drug Administration (FDA) approved the use of a gene-editing technology…
On Apr. 28, 2025, researchers at King’s College London, the University of Bristol and Great Ormond Street Hospital…
On Apr. 25, 2025, Amgen announced a $900 million expansion of its Ohio biotech manufacturing facility in New…
On Apr. 25, 2025, University of Washington announced that the Memory & Brain Wellness Center at Harborview Medical…
On Apr. 23, 2025, researchers from the Wellcome Sanger Institute, University of California San Diego and their collaborators…
On Apr. 21, 2025, the National Institutes of Health (NIH) reported that overall death rates from cancer declined steadily among…